2 enrolling by invitation. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Enrolling by invitation 2 |
| Phase 1 | 1 | Enrolling by invitation 1 |
Follow Children: new trials by email Literature Review of Children trials Research Report on Children
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma Nivolumab - Primary Mediastinal (Thymic) Large B-cell Lymphoma, Children | Phase 1 / Phase 2 | Enrolling by invitation | St. Petersburg State Pavlov Medical University | 22 | 2024-09-01 | 2025-03-11 |
| Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment Nivolumab - Relapsed or Refractory Hodgkin Lymphoma, Children | Phase 2 | Enrolling by invitation | St. Petersburg State Pavlov Medical University | 20 | 2022-06-01 | 2025-04-17 |
Hodgkin Disease (1) · Recurrence (1)
Disease Attributes (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Nivolumab (2) · Bendamustine Hydrochloride (1) · Cyclophosphamide (1) · Doxorubicin (1) · Etoposide (1) · Prednisolone (1) · Rituximab (1) · Vincristine (1)
St. Petersburg State Pavlov Medical University (2)
Russia (2)
Ludmila Zubarovskaya (1) · Natalya Myakova (1)